Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Dog Vaccines Market CAGR Outlook And Future Development
The dog vaccines market has experienced significant expansion over the past few years. This market is anticipated to expand from $3.8 billion in 2025 to $4.07 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. The growth observed historically can be attributed to factors such as a global increase in the dog population, heightened awareness concerning canine ailments, the introduction of novel vaccine categories, the development of veterinary healthcare infrastructure, and a rising prevalence of infectious canine diseases.
The dog vaccines market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $5.44 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.5%. This anticipated growth is driven by several factors, including breakthroughs in recombinant and DNA vaccine technologies, a heightened emphasis on preventive healthcare for canines, the broadening of veterinary immunization initiatives, increased funding for canine health research and development, and the integration of digital solutions for tracking vaccinations. Key trends anticipated during this period encompass a rise in vaccination awareness among dog owners, the creation of multivalent vaccines for dogs, greater uptake of preventive veterinary care, the broadening of vaccine schedules for pediatric and adult canines, and an increase in veterinary clinics providing full-spectrum immunization services.
Get A Free Sample Report With In-Depth Market Insights:
Dog Vaccines Market Growth Drivers: What’s Behind The Acceleration?
The increasing spread of zoonotic diseases is projected to stimulate the expansion of the dog vaccines market. These conditions, known as zoonoses, are infectious illnesses that can naturally transfer between animals and humans and vice versa. The rise in zoonotic diseases is attributed to human populations extending into wildlife environments, which heightens contact with animals and the risk of disease transmission. Dog vaccines play a vital role in preventing the transfer of zoonotic diseases from dogs to humans, thereby contributing to comprehensive public health strategies for controlling and managing such infections. For instance, in February 2023, findings from the Council on Foreign Relations (CFR), a US-based independent, nonpartisan member organization, think tank, and publisher, revealed that up to 75% of newly identified or emerging infectious diseases (EIDs) and 60% of recognized infectious diseases have zoonotic origins. Annually, zoonoses cause 2.7 million human fatalities and 2.5 billion disease episodes globally. Hence, the growing incidence of zoonotic diseases is propelling the growth of the dog vaccines market.
Dog Vaccines Market Segmentation: How Does The Market Break Down By Category?
The dog vaccines market covered in this report is segmented –
1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal
3) By Application: Below 6 Months, Above 6 Months
Subsegments:
1) By Attenuated Live Vaccines: Canine Parvovirus Vaccine, Canine Distemper Vaccine, Canine Adenovirus Vaccine
2) By Conjugate Vaccines: Canine Leptospira Vaccine, Canine Bordetella Vaccine
3) By Inactivated Vaccines: Canine Parvovirus Vaccine, Canine Influenza Vaccine
4) By Subunit Vaccines: Canine Lyme Disease Vaccine, Canine Parainfluenza Vaccine
5) By Toxoid Vaccines: Canine Leptospirosis Toxoid Vaccine
6) By DNA Vaccines: Canine Melanoma Vaccine
7) By Recombinant Vaccines: Canine Lyme Disease Recombinant Vaccine, Canine Bordetella Recombinant Vaccine
Dog Vaccines Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies in the dog vaccines market are prioritizing the development of innovative vaccine technologies, such as next-generation recombinant and RNA-based vaccines, to boost immune response, safety, and the duration of protection for companion animals. Next-generation canine vaccines are formulated to elicit targeted immunity through advanced platforms, while recombinant vaccines utilize specific antigens to minimize adverse reactions and improve efficacy. For example, in June 2024, Merck & Co. Inc.’s MSD Animal Health, a US-based animal health company, obtained approval from the United States Department of Agriculture (USDA) for Nobivac NXT Canine Influenza Virus (CIV), an RNA-particle vaccine for dogs. This represents a substantial leap in canine influenza prevention, offering a quick onset of immunity and superior protection against prevalent virus strains.
Dog Vaccines Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the dog vaccines market are Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, Dechra Pharmaceuticals PLC, Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S.A.
View The Full Dog Vaccines Market Report:
Dog Vaccines Market Geographic Distribution And Regional Opportunities
Asia-Pacific was the largest region in the dog vaccines market in 2025. The regions covered in the dog vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
